Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




MedPlast Acquires Orthoplastics Polyethylene Manufacturer

By HospiMedica International staff writers
Posted on 21 Oct 2013
MedPlast (Tempe, AZ, USA) has announced the purchase of Orthoplastics (Bacup; United Kingdom), a leading custom manufacturer of ultra-high molecular weight polyethylene (UHMWPE) products and components for the global OEM orthopedic device implant market.

MedPlast, a technology and innovative process leader in manufacturing support for Healthcare markets, intends to lever the purchase to create an expanded global footprint with orthopedic device OEMs, further enhancing its medical business segment. More...
The company already has expertise in injection molding, medical blow molding, silicone extrusion, compression and transfer molding, liquid injection molding (LIM), two-shot molding, over molding, insert molding, multicomponent molding, and precision mold making procedures.

Orthoplastics, besides being one of the major UHMWPE suppliers to the strictly regulated orthopedic implant market, has developed technology to produce premium grade UHMWPE implantable orthopedic components to customer specifications. A key feature offered is a patented method of gamma cross-linking in bulk with close dosage control. Other capabilities include direct compression molding (DCM), ram extrusion, annealing, machining and finishing, inspection, and laboratory testing.

“Orthoplastics becomes a key part of our strategy to deliver comprehensive processing technologies to the global medical device market,” said Matt Langton, executive vice president of sales and marketing for MedPlast. “This will provide our current and future customers with a wider range of capabilities that become even more valuable as the design of medical products grows increasingly sophisticated and regulated.”

“This acquisition allows MedPlast to combine its technical capabilities with Orthoplastics' implantable technologies to become a significant player in the implantable market,” said David Brooks, managing director of Orthoplastics.

UHMWPE is a subset of the thermoplastic polyethylene with extremely long chains that serve to transfer load more effectively to the polymer backbone by strengthening intermolecular interactions. The result is the highest impact strength thermoplastic presently made, highly resistant to corrosive chemicals except oxidizing acids, and with an extremely low moisture absorption and a very low coefficient of friction. Other benefits are that the material is self-lubricating and highly resistant to abrasion, in some forms being 15 times more resistant than carbon steel. Its coefficient of friction is significantly lower than that of nylon and is comparable to that of Teflon, but UHMWPE has better abrasion resistance.

Related Links:

MedPlast
Orthoplastics



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
ow Frequency Pulse Massager
ET10 L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.